Allergan signed off on requests from more than 25% of its shareholders calling for a special meeting, according to a person familiar with the matter
from WSJ.com: US Business http://ift.tt/1rAMamd
via IFTTT
from WSJ.com: US Business http://ift.tt/1rAMamd
via IFTTT
No comments:
Post a Comment